Study at a glance
What does “functional vitamin D status” mean?
This evidence review asks how vitamin D activity in the body differs from a blood-level measurement. The usual blood test measures 25-hydroxyvitamin D, shortened to 25(OH)D, to assess vitamin D supply. “Functional vitamin D status” refers to how well vitamin D-related processes are working. It is a research concept, not one standard clinical test.
How did people respond to vitamin D in these studies?
A randomised study of 35 healthy young adults compared a large vitamin D3 dose with a placebo, a treatment without vitamin D. Participants differed in blood measurements and changes in cell activity. Researchers used these changes to describe high, middle and low responses. Related research also found changes in how accessible parts of DNA were to the machinery controlling genes. These findings showed biological responses, not proven health benefits.
Did a proposed vitamin D test identify who would benefit?
A 2024 trial tested a proposed definition of functional deficiency based on several vitamin D measurements. In people meeting that definition, supplements changed vitamin D measurements and parathyroid hormone, a hormone involved in calcium control. However, the other tested measures of bone activity and risk relating to the heart and blood vessels did not show clear treatment effects. The proposed classification therefore needs further evaluation.
Do different responses establish a personal vitamin D target?
People can respond differently to vitamin D, but that does not establish a personal ideal blood level or justify progressively larger doses. Experimental response categories have not replaced the usual blood test. A new measure must show that it adds useful information for healthcare decisions, beyond demonstrating changes inside cells.
Read the full article below ↓Functional vitamin D status is best understood as a description of how effectively vitamin D-related biology is operating, not as a replacement name for a serum 25-hydroxyvitamin D [25(OH)D] concentration. Circulating 25(OH)D remains the principal practical biomarker used to estimate vitamin D status, but biological action continues beyond that measurement through transport, cellular uptake, local activation, degradation, vitamin D receptor signalling, chromatin regulation and tissue-specific responses. The distinction matters because two people with similar circulating concentrations need not show identical downstream responses, and because a molecular or physiological response measure does not automatically become a validated clinical test of “functional status.” This page develops the biological-response concept within the broader framework of Functional Vitamin D Status. For the concise version of this evidence review, see Functional Vitamin D Status: Biological Response Beyond Circulating Levels: Study Summary.
Measured status and biological response are different scientific objects
Serum 25(OH)D is useful because it integrates vitamin D entering from skin synthesis, food and supplements into a relatively stable circulating metabolite pool. That makes it practical for population assessment and clinical interpretation. It does not, however, directly measure the complete downstream sequence that produces vitamin D-dependent biological effects. The distinction is developed more generally in Vitamin D Status vs Vitamin D Effect and in What Vitamin D Levels Represent.
After 25(OH)D has been generated and circulated, it may be delivered to tissues in protein-bound or unbound forms, taken up by cells, converted by CYP27B1 to the active hormone 1,25-dihydroxyvitamin D [1,25(OH)₂D], degraded through CYP24A1-dependent pathways, and interpreted through the vitamin D receptor (VDR) in a cellular environment that differs between tissues. That is why Vitamin D Metabolism at the Cellular Level and Vitamin D Enzyme Pathways (CYP27B1/CYP24A1) are relevant to any serious account of functional response.
A functional concept asks what the vitamin D system is actually doing
If “functional vitamin D status” is used scientifically, the phrase should refer to evidence about biological activity rather than simply relabelling a blood concentration. Candidate dimensions can include endocrine adaptation such as parathyroid hormone (PTH), vitamin D metabolite relationships, changes in vitamin D-responsive gene expression, chromatin accessibility, immune-cell transcriptional responses or other validated physiological outcomes. None of these dimensions is automatically universal. A marker may be highly informative for one pathway yet weak for another, and an experimental molecular response may be valuable for mechanism without being suitable for routine clinical decision-making.
This endpoint dependence prevents the concept from collapsing into a single hidden “true vitamin D number.” A person’s bone-mineral response, immune-cell transcriptional response and tissue-specific intracrine activity are not necessarily interchangeable readouts. The relevant biological question therefore has to be specified before a functional measure can be interpreted. This is also why Vitamin D Response is a related but distinct concept: response describes the change produced by an exposure or intervention, whereas functional status attempts to describe the biological state or competence of the pathway at a given time.
Human intervention studies demonstrate measurable response heterogeneity
The VitDbol intervention programme provides an important proof of principle because it moved beyond serum concentration alone and examined molecular responses after vitamin D₃ exposure. In a randomized study of 35 healthy young adults, a large oral vitamin D₃ bolus or placebo was followed by repeated measurements that included circulating vitamin D metabolites, PTH and molecular readouts. The investigators observed substantial inter-individual variation and classified participants into high, mid and low response groups using changes in vitamin D-sensitive molecular and biochemical parameters.
The importance of that result is not that the three categories should be copied directly into clinical practice. Its importance is evidential: a single 25(OH)D concentration did not capture all of the biological information seen after the intervention. Participants differed not only in circulating metabolite responses but also in downstream molecular behaviour. This is consistent with the broader point made by Vitamin D Beyond Numbers: a laboratory value can be scientifically important without exhausting the physiology that lies behind it.
A related proof-of-principle experiment examined chromatin accessibility in peripheral blood mononuclear cells before and after repeated vitamin D₃ boluses. Even relatively modest short-term increases in serum 25(OH)D₃ were accompanied by significant changes in chromatin accessibility at hundreds of genomic sites. That observation matters because it provides direct in-vivo evidence that vitamin D exposure can alter a biological layer downstream of the circulating biomarker. It also reinforces the relevance of Vitamin D and Epigenetic Regulation.
VDR signalling gives functional response a cellular meaning
The active vitamin D hormone exerts much of its genomic action through VDR. The receptor binds ligand, interacts with regulatory regions of DNA in cooperation with other transcriptional machinery, and can influence networks of target genes. A functional response therefore depends not merely on the amount of precursor in blood but on the capacity of cells to receive, activate and interpret that signal. Differences in receptor abundance, cellular context, chromatin state and regulatory cofactors can all affect what a given hormonal signal produces. The related page Vitamin D Receptor Sensitivity and Density develops that part of the pathway.
This does not mean that every difference in gene expression is clinically meaningful. Molecular responsiveness is a mechanistic layer, not an automatic surrogate for health benefit. A vitamin D-responsive transcript may establish pathway activity without proving that increasing that transcript improves a patient-important outcome. Functional assessment therefore has an epistemic ceiling: the farther a proposed marker sits from an established clinical endpoint, the more carefully its meaning must be bounded.
Transport and metabolite handling also shape what reaches tissues
Most circulating 25(OH)D is bound to vitamin D-binding protein (DBP), with a smaller albumin-bound fraction and a very small free fraction. Binding affects transport, distribution and the relationship between total measured concentration and what is available to particular tissues. The biology is more complex than a simple claim that “free vitamin D is the only active vitamin D,” because some tissues can internalize DBP-bound metabolites through receptor-mediated mechanisms. The distinctions in Vitamin D Binding Protein Explained and Free vs Total Vitamin D Explained therefore belong to the functional-status discussion without replacing 25(OH)D as the standard status biomarker.
A proposed functional marker has to prove that it adds clinically useful information
The strongest caution comes from attempts to formalize “functional vitamin D deficiency” using metabolite patterns. A 2024 randomized controlled trial examined a classification combining low 25(OH)D, low 24,25-dihydroxyvitamin D and a low vitamin D metabolite ratio. The rationale was biologically plausible: 24,25(OH)₂D reflects catabolism of 25(OH)D, so a low ratio might identify a state in which the organism has high vitamin D requirements or reduced metabolic throughput.
But biological plausibility did not translate into broad predictive clinical utility in that trial. Among participants classified as functionally deficient, vitamin D supplementation changed PTH and vitamin D metabolites as expected but did not produce significant treatment effects across the other tested bone-metabolism and cardiovascular-risk outcomes. The investigators concluded that the clinical significance of the proposed classification requires further evaluation. That result is central because it prevents a mechanistic idea from being promoted prematurely into a universal diagnostic category.
Functional status should not be confused with an individualized target concentration
Response heterogeneity can tempt a second overreach: if people differ biologically, perhaps each person must have a unique optimal serum 25(OH)D target. The evidence does not justify that inference. Demonstrating that individuals differ in molecular or biochemical response proves heterogeneity; it does not by itself identify a validated target concentration for each person. That distinction is developed in Vitamin D Thresholds vs Targets.
The same caution applies to proposed personal response indices. Such indices can be useful research tools for studying how strongly molecular endpoints respond to vitamin D exposure. Their existence does not make them routine clinical tests, and it does not establish that a low molecular responder should simply receive progressively larger doses until a selected gene-expression endpoint changes. Dose, safety, endpoint relevance and clinical outcomes remain separate questions.
What functional vitamin D status can legitimately mean today
At present, the defensible scientific meaning is layered. Serum 25(OH)D describes circulating vitamin D status. Downstream functional assessment asks whether vitamin D-related physiology is being activated and expressed through relevant biochemical, endocrine, cellular or molecular pathways. The two can inform one another, but they are not interchangeable. A functional perspective is especially useful for explaining why a blood concentration cannot be assumed to encode every aspect of vitamin D biology.
The practical conclusion is therefore deliberately restrained. Functional vitamin D status is a useful physiological framework and an active research concept, supported by evidence that people can differ in downstream biological response. It is not yet a single standardized clinical quantity, and no molecular response index, metabolite ratio or gene-expression panel has displaced serum 25(OH)D as the routine status measure. The most accurate interpretation keeps measurement and function connected without pretending that they are the same thing.
Primary scientific sources and publication details
Seuter S, Virtanen JK, Nurmi T, Pihlajamäki J, Mursu J, Voutilainen S, Tuomainen T-P, Neme A, Carlberg C. Molecular evaluation of vitamin D responsiveness of healthy young adults. Journal of Steroid Biochemistry and Molecular Biology. 2017;174:314-321. PMID: 27282116. DOI: 10.1016/j.jsbmb.2016.06.003.
Carlberg C, Seuter S, Nurmi T, Tuomainen T-P, Virtanen JK, Neme A. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. Journal of Steroid Biochemistry and Molecular Biology. 2018;180:142-148. PMID: 29317287. DOI: 10.1016/j.jsbmb.2018.01.002.
Carlberg C, Haq A. The concept of the personal vitamin D response index. Journal of Steroid Biochemistry and Molecular Biology. 2018;175:12-17. PMID: 28034764.
Zelzer S, Meinitzer A, Enko D, et al. Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients. Nutrients. 2024;16(6):839. PMID: 38542750. PMCID: PMC10975656. DOI: 10.3390/nu16060839.
Related reading
Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients
We, therefore, evaluated whether the classification of “functional vitamin D deficiency”, i.e., 25(OH)D below 50 nmol/L, 24,25(OH)2D below 3 nmol/L and a VMR of less than 4%, identifies individuals who benefit from vitamin D supplementation.
Original paper ↗Read more →Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients
In this work, we aim to evaluate the hypothesis that the definition of functional vitamin D deficiency is able to identify individuals who significantly benefit from vitamin D supplementation.
Original paper ↗Read more →Aqueous Extract of Mori Folium Exerts Bone Protective Effect Through Regulation of Calcium and Redox Homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-κB Signaling in Diabetic Rats
The present study is aimed to explore whether the aqueous extract of Mori Folium (MF) exhibits bone protective effect by regulating calcium and redox homeostasis in diabetic rats, and to identify the signaling pathways involved in this process.
Original paper ↗Read more →A parathyroid hormone/salt-inducible kinase signaling axis controls renal vitamin D activation and organismal calcium homeostasis
The renal actions of parathyroid hormone (PTH) promote 1,25-vitamin D generation; however, the signaling mechanisms that control PTH-dependent vitamin D activation remain unknown.
Original paper ↗Read more →Arterial Structure and Function in Mild Primary Hyperparathyroidism Is Not Directly Related to Parathyroid Hormone, Calcium, or Vitamin D
We evaluated the possible vascular effects of these risk factors in patients with mild PHPT by using standard methods and new imaging techniques.
Original paper ↗Read more →Association between 25-Hydroxyvitamin D, Parathyroid Hormone, Vitamin D and Calcium Intake, and Bone Density in Healthy Adult Women: A Cross-Sectional Analysis from the D-SOL Study
This cross-sectional analysis aimed to investigate the associations of 25(OH)D and plasma PTH concentrations with bone parameters, and potential confounders, in women living in a high (England) or low (Brazil) latitude country.
Original paper ↗Read more →Associations of Vitamin D Deficiency, Parathyroid hormone, Calcium, and Phosphorus with Perinatal Adverse Outcomes. A Prospective Cohort Study
We aimed to evaluate the association of vitamin D deficiency during early pregnancy with preterm birth.
Original paper ↗Read more →Changes in the Calcium-Parathyroid Hormone-Vitamin D Axis and Prognosis for Critically Ill Patients: A Prospective Observational Study
Vitamin D deficiency is prevalent in critically ill patients and may contribute to suboptimal clinical outcomes, but little is known about alterations of the calcium-parathyroid hormone (PTH)-vitamin D axis and prognosis in these individuals.
Original paper ↗Read more →Genetic association of serum calcium, phosphate, vitamin D, parathyroid hormone, and FGF23 with the risk of aortic stenosis
However, evidence of the causal role of mineral metabolism in CAVS is still lacking.
Original paper ↗Read more →Interactions between Vitamin D Status, Calcium Intake and Parathyroid Hormone Concentrations in Healthy White-Skinned Pregnant Women at Northern Latitude
Little explored in pregnancy, we aimed to examine the relative importance of serum 25-hydroxyvitamin D (25(OH)D) and calcium intake on parathyroid hormone (PTH) concentrations in healthy white-skinned pregnant women.
Original paper ↗Read more →Postprandial metabolic responses of serum calcium, parathyroid hormone and C-telopeptide of type I collagen to three doses of calcium delivered in milk
The present study investigated Ca absorption patterns with increasing levels of fortification in milk, and the response to one dose of a Ca salt.
Original paper ↗Read more →R990G Polymorphism of Calcium Sensing Receptor Gene Is Associated with High Parathyroid Hormone Levels in Subjects with Vitamin D Deficiency: A Cross-Sectional Study
Single nucleotide polymorphisms (SNPs), R990G and A986S of the calcium sensing receptor (CaSR) gene, are shown to influence response of parathyroid hormone (PTH) in subjects with optimal vitamin D levels.
Original paper ↗Read more →Serum levels of vitamin D, parathyroid hormone and calcium in relation to survival following breast cancer
The aim of this study was to examine pre-diagnostic levels of vitamin D (25OHD), PTH and calcium in relation to survival after breast cancer.
Original paper ↗Read more →The Influence of Different Cholecalciferol Supplementation Regimes on 25(OH) Cholecalciferol, Calcium and Parathyroid Hormone after Bariatric Surgery
Background and objectives: Vitamin D is an essential vitamin that plays a key role in maintaining physiological calcium balance, and is also a pivotal element in the formation of bone structure.
Original paper ↗Read more →The Role of Calcium, 25-Hydroxyvitamin D, and Parathyroid Hormone in Irritable Bowel Syndrome: A Bidirectional Two-Sample Mendelian Randomization Study
Therefore, we aimed to explore the bidirectional causal effects among serum calcium, Vit-D, PTH, and IBS at the genetic level by a two-sample Mendelian randomization (MR) analysis of the datasets from IEU OpenGWAS database.
Original paper ↗Read more →Vitamin D, Calcium, Parathyroid Hormone, and Sex Steroids in Bone Health and Effects of Aging
Bone health of the elderly is a major global health concern, since about 1 in 3 women and 1 in 5 men suffer from bone loss and fractures, often called osteoporosis, in old age.
Original paper ↗Read more →VDR, PDIA3 and Rapid Calcium Signalling in A431 Cells: Full Evidence Review
Examine minute-scale calcium responses and later reporter activity in A431 carcinoma cells, with limits on receptor dependence and clinical interpretation.
Read more →Relationship Between Total 25-Hydroxyvitamin D and Parathyroid Hormone Concentrations During Early Gestation in Indian Women
The inverse relationship between 25(OH)D and parathyroid hormone (PTH) concentrations was examined to define the breakpoint at which PTH was maximally suppressed using a segmented regression analysis.
Original paper ↗Read more →Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study
Therefore, we investigated whether lower 25-hydroxyvitamin D (25(OH)D) and higher PTH are cross sectionally and after 8 years of follow-up associated with higher B-type natriuretic peptide (BNP) levels in older men and women.
Original paper ↗Read more →Serum Parathyroid Hormone, 25-Hydroxyvitamin D, and Risk of Alzheimer’s Disease: A Mendelian Randomization Study
We conducted Mendelian randomization analyses to investigate the associations of serum parathyroid hormone (S-PTH) and serum 25-hydroxyvitamin D (S-25OHD) concentrations with Alzheimer’s disease (AD).
Original paper ↗Read more →Threshold of 25(OH)D and consequently adjusted parathyroid hormone reference intervals: data mining for relationship between vitamin D and parathyroid hormone
By recruiting reference population, we aimed to (1): estimate the 25(OH)D threshold that maximally inhibits the PTH, which can be defined as the cutoff value for vitamin D sufficiency; (2) establish the PTH reference interval (RI) in population with sufficient vitamin D.
Original paper ↗Read more →Original sources
Molecular evaluation of vitamin D responsiveness of healthy young adults
Published in Journal of Steroid Biochemistry and Molecular Biology (2017).
Publication details
Seuter S, Virtanen JK, Nurmi T, Pihlajamäki J, Mursu J, Voutilainen S, Tuomainen T-P, Neme A, Carlberg C. Molecular evaluation of vitamin D responsiveness of healthy young adults. Journal of Steroid Biochemistry and Molecular Biology. 2017;174:314-321. PMID: 27282116. DOI: 10.1016/j.jsbmb.2016.06.003.
In vivo response of the human epigenome to vitamin D: A Proof-of-principle study
Published in Journal of Steroid Biochemistry and Molecular Biology (2018).
Publication details
Carlberg C, Seuter S, Nurmi T, Tuomainen T-P, Virtanen JK, Neme A. In vivo response of the human epigenome to vitamin D: A Proof-of-principle study. Journal of Steroid Biochemistry and Molecular Biology. 2018;180:142-148. PMID: 29317287. DOI: 10.1016/j.jsbmb.2018.01.002.
The concept of the personal vitamin D response index
Published in Journal of Steroid Biochemistry and Molecular Biology (2018).
Publication details
Carlberg C, Haq A. The concept of the personal vitamin D response index. Journal of Steroid Biochemistry and Molecular Biology. 2018;175:12-17. PMID: 28034764.
Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients
We, therefore, evaluated whether the classification of “functional vitamin D deficiency”, i.e., 25(OH)D below 50 nmol/L, 24,25(OH)2D below 3 nmol/L and a VMR of less than 4%, identifies individuals who benefit from vitamin D supplementation.
Publication details
Zelzer S, Meinitzer A, Enko D, et al. Classification of Vitamin D Status Based on Vitamin D Metabolism: A Randomized Controlled Trial in Hypertensive Patients. Nutrients. 2024;16(6):839. PMID: 38542750. PMCID: PMC10975656. DOI: 10.3390/nu16060839.